Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (463) Health Services in Resource-Poor Settings and LMICs (585) Infectious Diseases (non-STD/STI) (1768) Outbreak and Pandemic Preparedness and Management (1855) COVID-19 Vaccination (190)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/81323, first published .
Safety, Tolerability, and Immunogenicity of the TANCoV-1.3.20 SARS-CoV-2 Vaccine Among Healthy Participants in Tanzania: Protocol for a Multisite, Phase 1/2a, Double-Blinded Randomized Controlled Trial

Safety, Tolerability, and Immunogenicity of the TANCoV-1.3.20 SARS-CoV-2 Vaccine Among Healthy Participants in Tanzania: Protocol for a Multisite, Phase 1/2a, Double-Blinded Randomized Controlled Trial

Safety, Tolerability, and Immunogenicity of the TANCoV-1.3.20 SARS-CoV-2 Vaccine Among Healthy Participants in Tanzania: Protocol for a Multisite, Phase 1/2a, Double-Blinded Randomized Controlled Trial

Authors of this article:

George Peter Judicate1, 2 Author Orcid Image ;   Marco Missanga3 Author Orcid Image ;   Mbazi Senkoro1 Author Orcid Image ;   Emmanuel Kapesa3 Author Orcid Image ;   Nhamo Chiwerengo4 Author Orcid Image ;   Redemta Ferdinand1 Author Orcid Image ;   Gibson Kagaruki1 Author Orcid Image ;   Godfather Kimaro1 Author Orcid Image ;   Esther Ngadaya1 Author Orcid Image ;   Sokoine Lesikari Kivuyo1 Author Orcid Image ;   Deus Buma5 Author Orcid Image ;   Lwitiho Sudi3 Author Orcid Image ;   Abisai Kisinda3 Author Orcid Image ;   Lucas Maganga3 Author Orcid Image ;   Doreen Pamba3 Author Orcid Image ;   Joel Mwakisisile3 Author Orcid Image ;   Willyhelmina Olomi4 Author Orcid Image ;   Nyanda Ntinginya Elias3 Author Orcid Image ;   Said Aboud6 Author Orcid Image ;   Philemon Wambura7 Author Orcid Image ;   Sayoki Mfinanga1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

George Peter Judicate   1, 2 , MD, PhD ;   Marco Missanga   3 , MMed, MD ;   Mbazi Senkoro   1 , MD, MPhil, PhD ;   Emmanuel Kapesa   3 , MD ;   Nhamo Chiwerengo   4 , AdvDip ;   Redemta Ferdinand   1 , MD ;   Gibson Kagaruki   1 , BSc, MSc, PhD ;   Godfather Kimaro   1 , MIH, MD ;   Esther Ngadaya   1 , MSc, MD, PhD ;   Sokoine Lesikari Kivuyo   1 , MPhil, MD ;   Deus Buma   5 , BPharm, MPharm, PhD ;   Lwitiho Sudi   3 , BSc, MSc ;   Abisai Kisinda   3 , BSc, MSc ;   Lucas Maganga   3 , MPH, MD ;   Doreen Pamba   3 , BSc, MSc ;   Joel Mwakisisile   3 , MSc, MD ;   Willyhelmina Olomi   4 , BSc, MSc ;   Nyanda Ntinginya Elias   3 , MSc, MD, PhD ;   Said Aboud   6 , MMed, MD, PhD ;   Philemon Wambura   7 , BSc, MSc, PhD ;   Sayoki Mfinanga   1 , MD, PhD

1 Research Department, National Institute for Medical Research, Muhimbili Center, Dar es Salaam, United Republic of Tanzania

2 Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania

3 Research Department, National Institute for Medical Research, Mbeya, United Republic of Tanzania

4 Data Management, National Institute for Medical Research, Mbeya, United Republic of Tanzania

5 Department of Pharmacy, Muhimbili National Hospital, Dar es Salaam, United Republic of Tanzania

6 Research Department, National Institute for Medical Research, Headquarters, Dar es Salaam, United Republic of Tanzania

7 Department of Microbiology, Sokoine University of Agriculture, Morogoro, United Republic of Tanzania

Corresponding Author:

  • George Peter Judicate, MD, PhD
  • Research Department
  • National Institute for Medical Research, Muhimbili Center
  • PO Box 3436
  • Dar es Salaam
  • United Republic of Tanzania
  • Phone: 255 222121400
  • Email: judicategeorge@yahoo.com